Recruiting
Phase 1

Avapritinib with Decitabine

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Code:

NCT06327685

Conditions

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Avapritinib

Decitabine

Decitabine/Cedazuridine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-11. This information was provided to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute on 2025-03-12.